Skip to content

Hyalofast

by Anika Therapeutics S.R.L. 2 variants

Ref 144722F

Active European Union

CE MDR CE MDD

Valid until

9 Feb 2030

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier BSI Group The Netherlands B.V.

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD Number08033549HYALTHU Basic UDI-DI Date17 Aug 2026RegisteredStatusActive
European UnionCE/MDR Number08033549HYALTHU Basic UDI-DI Date17 Aug 2026RegisteredStatusActive

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • MDR 845084 Active

    Technical documentation EU MDR

    Certifier
    BSI Group The Netherlands B.V. 2797
    Issued
    10 Aug 2026
    Expires
    9 Feb 2030
    Valid from
    15 Aug 2026

Coverage

1 jurisdiction

Italy
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDD, CE/MDR Active

  • Italy

Specification

EUDAMED

Model / Reference
144722F
Primary DI / UDI-DI
08033549791148, 08033549790578
Basic UDI-DI
08033549HYALTHU, B-08033549790578
EMDN Code
P900402, P900401
Device Class
Class III
EU market of registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000028141

Other devices from Anika Therapeutics S.R.L.

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No